11,071 Shares in Doximity, Inc. (NASDAQ:DOCS) Purchased by Bryce Point Capital LLC

Bryce Point Capital LLC acquired a new stake in Doximity, Inc. (NASDAQ:DOCS) in the 4th quarter, according to the company in its most recent filing with the SEC. The firm acquired 11,071 shares of the company’s stock, valued at approximately $591,000.

Other hedge funds have also recently modified their holdings of the company. Shaker Investments LLC OH bought a new position in Doximity in the 4th quarter valued at $559,000. Principal Financial Group Inc. boosted its holdings in shares of Doximity by 1.5% in the 4th quarter. Principal Financial Group Inc. now owns 293,974 shares of the company’s stock worth $15,695,000 after buying an additional 4,282 shares during the last quarter. Newbridge Financial Services Group Inc. bought a new position in Doximity during the fourth quarter valued at about $362,000. Stratos Wealth Partners LTD. purchased a new stake in Doximity during the fourth quarter worth about $203,000. Finally, Barclays PLC raised its position in Doximity by 60.5% in the third quarter. Barclays PLC now owns 53,401 shares of the company’s stock worth $2,327,000 after acquiring an additional 20,125 shares during the period. Institutional investors own 87.19% of the company’s stock.

Insider Transactions at Doximity

In related news, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the transaction, the director now directly owns 6,360 shares of the company’s stock, valued at $366,463.20. This represents a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 37.40% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently weighed in on DOCS shares. Wells Fargo & Company reissued an “equal weight” rating on shares of Doximity in a research report on Friday, February 7th. Bank of America boosted their target price on Doximity from $54.00 to $57.00 and gave the company a “neutral” rating in a research note on Monday, January 6th. Needham & Company LLC increased their price target on Doximity from $65.00 to $82.00 and gave the stock a “buy” rating in a research note on Friday, February 7th. Piper Sandler raised shares of Doximity from a “neutral” rating to an “overweight” rating and upped their price objective for the company from $31.00 to $78.00 in a report on Friday, February 7th. Finally, The Goldman Sachs Group increased their target price on shares of Doximity from $58.00 to $80.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Eleven equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Doximity has an average rating of “Moderate Buy” and an average target price of $64.22.

Doximity Stock Up 2.2 %

Shares of DOCS stock opened at $57.96 on Thursday. The firm has a market capitalization of $10.82 billion, a price-to-earnings ratio of 57.96, a PEG ratio of 4.10 and a beta of 1.34. The stock has a fifty day moving average of $65.63 and a 200 day moving average of $54.84. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $85.21.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.